# Cannabidiol as a Treatment for AUD Comorbid With PTSD

> **NCT03248167** · PHASE1,PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 95 (actual)

## Conditions studied

- Alcohol Use Disorder
- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03248167
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-16
- **Primary completion:** 2022-04-20
- **Final completion:** 2022-04-20
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248167, "Cannabidiol as a Treatment for AUD Comorbid With PTSD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03248167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*